| 1 Lack of moderate/marked improvement (FGIR) Show forest plot | 1 | | Risk Ratio (M‐H, Random, 95% CI) | Subtotals only |
|
| 1.1 Mexazolam | 1 | 134 | Risk Ratio (M‐H, Random, 95% CI) | 1.13 [0.85, 1.49] |
| 2 Number of subjects reporting side‐effects Show forest plot | 1 | 134 | Risk Ratio (M‐H, Random, 95% CI) | 0.90 [0.46, 1.78] |
|
| 3 Side‐effects Show forest plot | 2 | | Risk Ratio (M‐H, Random, 95% CI) | Subtotals only |
|
| 3.1 agression | 1 | 32 | Risk Ratio (M‐H, Random, 95% CI) | 0.0 [0.0, 0.0] |
| 3.2 allergic reaction | 2 | 166 | Risk Ratio (M‐H, Random, 95% CI) | 0.94 [0.22, 4.07] |
| 3.3 ataxia | 1 | 32 | Risk Ratio (M‐H, Random, 95% CI) | 0.50 [0.11, 2.35] |
| 3.4 confusion | 1 | 32 | Risk Ratio (M‐H, Random, 95% CI) | 1.0 [0.30, 3.32] |
| 3.5 disinhibition | 1 | 32 | Risk Ratio (M‐H, Random, 95% CI) | 0.0 [0.0, 0.0] |
| 3.6 dizziness | 2 | 166 | Risk Ratio (M‐H, Random, 95% CI) | 0.89 [0.44, 1.82] |
| 3.7 drowsiness | 2 | 166 | Risk Ratio (M‐H, Random, 95% CI) | 0.56 [0.20, 1.59] |
| 3.8 dyspnea | 1 | 32 | Risk Ratio (M‐H, Random, 95% CI) | 0.2 [0.01, 3.86] |
| 3.9 hyporeflexia | 1 | 32 | Risk Ratio (M‐H, Random, 95% CI) | 0.33 [0.01, 7.62] |
| 3.10 respiratory depression | 1 | 32 | Risk Ratio (M‐H, Random, 95% CI) | 0.14 [0.01, 2.56] |
| 3.11 slurred speech | 1 | 32 | Risk Ratio (M‐H, Random, 95% CI) | 0.0 [0.0, 0.0] |
| 3.12 abdominal fullness | 1 | 134 | Risk Ratio (M‐H, Random, 95% CI) | 0.38 [0.02, 9.04] |
| 3.13 abnormality of salivation | 1 | 134 | Risk Ratio (M‐H, Random, 95% CI) | 3.38 [0.14, 81.39] |
| 3.14 anorexia | 1 | 134 | Risk Ratio (M‐H, Random, 95% CI) | 5.63 [0.28, 114.99] |
| 3.15 blurred vision | 1 | 134 | Risk Ratio (M‐H, Random, 95% CI) | 3.38 [0.14, 81.39] |
| 3.16 chest discomfort | 1 | 134 | Risk Ratio (M‐H, Random, 95% CI) | 3.38 [0.14, 81.39] |
| 3.17 constipation | 1 | 134 | Risk Ratio (M‐H, Random, 95% CI) | 0.38 [0.02, 9.04] |
| 3.18 diarrhea | 1 | 134 | Risk Ratio (M‐H, Random, 95% CI) | 5.63 [0.28, 114.99] |
| 3.19 discouragement | 1 | 134 | Risk Ratio (M‐H, Random, 95% CI) | 0.38 [0.02, 9.04] |
| 3.20 fatigue | 1 | 134 | Risk Ratio (M‐H, Random, 95% CI) | 5.63 [0.28, 114.99] |
| 3.21 headache | 1 | 134 | Risk Ratio (M‐H, Random, 95% CI) | 0.38 [0.02, 9.04] |
| 3.22 heart pressure | 1 | 134 | Risk Ratio (M‐H, Random, 95% CI) | 3.38 [0.14, 81.39] |
| 3.23 inarticulateness | 1 | 134 | Risk Ratio (M‐H, Random, 95% CI) | 0.38 [0.02, 9.04] |
| 3.24 light head feeling | 1 | 134 | Risk Ratio (M‐H, Random, 95% CI) | 0.23 [0.01, 4.60] |
| 3.25 nausea | 1 | 134 | Risk Ratio (M‐H, Random, 95% CI) | 0.38 [0.02, 9.04] |
| 3.26 numbness | 1 | 134 | Risk Ratio (M‐H, Random, 95% CI) | 1.13 [0.07, 17.65] |
| 3.27 stomach ache | 1 | 134 | Risk Ratio (M‐H, Random, 95% CI) | 1.13 [0.07, 17.65] |
| 3.28 thirst | 1 | 134 | Risk Ratio (M‐H, Random, 95% CI) | 0.38 [0.02, 9.04] |
| 3.29 weakness | 1 | 134 | Risk Ratio (M‐H, Random, 95% CI) | 3.38 [0.14, 81.39] |
| 4 Dropout Show forest plot | 2 | 170 | Risk Ratio (M‐H, Random, 95% CI) | 1.43 [0.77, 2.69] |
|
| 4.1 Oxazepam | 1 | 36 | Risk Ratio (M‐H, Random, 95% CI) | 1.0 [0.16, 6.35] |
| 4.2 Mexazolam | 1 | 134 | Risk Ratio (M‐H, Random, 95% CI) | 1.50 [0.77, 2.93] |
| 5 Impairment of job performance Show forest plot | 1 | 32 | Risk Ratio (M‐H, Random, 95% CI) | 0.67 [0.38, 1.17] |
|
